Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

BACKGROUND: Fibroblast growth factor 23 (FGF-23) is a hormone that increases the rate of urinary excretion of phosphate and inhibits renal production of 1,25-dihydroxyvitamin D, thus helping to mitigate hyperphosphatemia in patients with kidney disease. Hyperphosphatemia and low 1,25-dihydroxyvitami...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Gutiérrez, Orlando M., Mannstadt, Michael, Isakova, Tamara, Rauh-Hain, Jose Alejandro, Tamez, Hector, Shah, Anand, Smith, Kelsey, Lee, Hang, Thadhani, Ravi, Jüppner, Harald, Wolf, Myles
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2008
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2890264/
https://ncbi.nlm.nih.gov/pubmed/18687639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa0706130
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller